<DOC>
	<DOCNO>NCT00292487</DOCNO>
	<brief_summary>The purpose study compare incidence contrast induced nephrotoxicity follow administration Isovue Visipaque patient mild moderate renal impairment undergo clinically indicate IV contrast-enhanced ( multidetector compute tomography ) MDCT liver MDCT angiography low extremity . Serum Creatinine ( SCr ) measure 48-72 hour post dose .</brief_summary>
	<brief_title>Patients With Renal Impairment Undergoing CT</brief_title>
	<detailed_description />
	<criteria>refer MDCT liver peripheral CTA stable baseline SCr 1.5 2.5 mg/dL and/or calculate CrCl 1060 mL/min unstable renal function require prophylactic drug receive contrast ( hydration ) uncontrolled diabetes currently dialysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2006</verification_date>
</DOC>